Cargando…

Vitamin D for COVID-19: where are we now?

Vitamin D has received much interest during the COVID-19 pandemic as a potential prophylactic or therapeutic agent — but do the available data support its use?

Detalles Bibliográficos
Autores principales:	Martineau, Adrian R., Cantorna, Margherita T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305676/ https://www.ncbi.nlm.nih.gov/pubmed/35869321 http://dx.doi.org/10.1038/s41577-022-00765-6

Ejemplares similares

COVID-19 and liver disease: where are we now?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

Vitamin D for COVID-19: a case to answer?
por: Martineau, Adrian R, et al.
Publicado: (2020)

The impact of ICCPR's Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go?
por: Turk-Adawi, Karam, et al.
Publicado: (2023)

Genomic testing for rare disease diagnosis—where are we now, and where should we be heading? The reflections of a behavioural scientist
por: Lewis, Celine
Publicado: (2023)

COVID-19 herd immunity: where are we?
por: Fontanet, Arnaud, et al.
Publicado: (2020)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Living with the COVID-19 pandemic: act now with the tools we have
por: Bedford, Juliet, et al.
Publicado: (2020)

Fluvoxamine for outpatients with COVID-19: where do we stand?
por: Berwanger, Otavio
Publicado: (2022)

Vitamin E: Where Are We Now in Vascular Diseases?
por: Garg, Anahita, et al.
Publicado: (2022)

Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?
por: Khawaja, Fareed, et al.
Publicado: (2022)

Comment on Sah et al. Monkeypox and Its Possible Sexual Transmission: Where Are We Now with Its Evidence? Pathogens 2022, 11, 924
por: Vera, Milagros Nilda, et al.
Publicado: (2022)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Post-COVID-19 Condition: Where Are We Now?
por: Boaventura, Paula, et al.
Publicado: (2022)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?
por: Falchetti, A., et al.
Publicado: (2021)

The time to do serosurveys for COVID-19 is now
por: Peeling, Rosanna W, et al.
Publicado: (2020)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

The influenza imperative: we must prepare now for seasonal and pandemic influenza
por: Dzau, Victor, et al.
Publicado: (2023)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Child malnutrition and COVID-19: the time to act is now
por: Fore, Henrietta H, et al.
Publicado: (2020)

Two years of COVID-19 pandemic: where are we now?
por: Myoung, Jinjong
Publicado: (2022)

The COVID-19 Vaccine in Clinical Trials: Where Are We Now?
por: Jiang, Hu-Dachuan, et al.
Publicado: (2021)

Lung cancer and Covid-19: lessons learnt from the pandemic and where do we go from here?
por: Maxwell, Susanne Sarah, et al.
Publicado: (2022)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Elective orthopaedic cancellations due to the COVID-19 pandemic: where are we now, and where are we heading?
por: Oussedik, Sam, et al.
Publicado: (2021)

Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury
por: Froicu, Monica, et al.
Publicado: (2007)

The impact of COVID-19 on O&G trainees; where are we now?
por: Duggan, I, et al.
Publicado: (2022)

Offline: COVID-19—what countries must do now
por: Horton, Richard
Publicado: (2020)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ak6h2lq6fojfk1gkdnhu787njb